Results 171 to 180 of about 55,171 (227)

Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study. [PDF]

Lancet Microbe
Martínez-Martínez FJ, Chiner-Oms Á, Furió V, HpGP Research Network, Yamaoka Y, Dekker JP, Mégraud F, Bénéjat L, Ducournau A, Giese A, Jehanne Q, Jauvain M, Camargo MC, Comas I, Lehours P.   +14 more
europepmc   +1 more source

Improving Helicobacter pylori Treatment Standards: A Quality Improvement Project Against Maastricht VI Guidelines. [PDF]

Cureus
Varier S, Mansingh M, Patel D, Desai B, Shah YM, Omar MA.   +5 more
europepmc   +1 more source

Multiphasic anaphylaxis in the emergency and intensive care setting. [PDF]

BMJ Case Rep
Schneider MA, de Groot H, Geerts JW.
europepmc   +1 more source

Therapeutic advances and future directions in <i>Helicobacter pylori</i> eradication. [PDF]

Front Microbiol
Suresh V, Sreekumar A, Kumar A, Sadasivan S, Biswas R, Biswas L.   +5 more
europepmc   +1 more source

Retrospective Comparison of Conventional Triple Therapy and Levofloxacin-Based Sequential Therapy for Helicobacter pylori Eradication in Mardan Medical Complex. [PDF]

Cureus
Naeem M, Hussain M.
europepmc   +1 more source

High Prevalence of <i>hefA</i> Efflux Pump Overexpression in Isolates of <i>Helicobacter pylori</i> Resistant to Clarithromycin. [PDF]

Antibiotics (Basel)
Villegas M, Ortega C, Gómez K, Cerda A, Sepúlveda R, Lara C, Bustamante L, Garcia D, Coppelli L, Hofmann E, Sierralta A, Pavez M.   +11 more
europepmc   +1 more source

Whole genome sequence analysis of <i>Helicobacter pylori</i> isolates reveals incomplete characterization of antimicrobial resistance mechanisms. [PDF]

iScience
Vieni C, Rothstein T, Johnson S, Schuetz AN, Norgan A, Patel R.   +5 more
europepmc   +1 more source

Whole-genome and pangenome insights into <i>Mycobacterium colombiense</i> clinical isolates from human infections. [PDF]

PeerJ
Oungbamnet C, Hinwan Y, Nithimongkolchai N, Sawaswong V, Chitcharoen S, Faksri K, Sirichoat A.   +6 more
europepmc   +1 more source

Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line <i>Helicobacter pylori</i> eradication: a double-blind randomized controlled trial. [PDF]

Lancet Reg Health Am
Medel-Jara PA, Latorre G, Fuentes-Lopez E, Pizarro M, Viviani P, Chahuán J, Maquilón S, Corsi O, Reyes D, Espino A, Vargas JI, Wichmann IA, Harris P, Serrano C, Buruato I, Sandoval C, Varela NM, Cerpa L, Quiñones L, Megraud F, Huang RJ, Shah SC, Perez AR.   +22 more
europepmc   +1 more source